Chan SL - Search Results

1

Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region.

Kim DY, Toan BN, Tan CK, Hasan I, Setiawan L, Yu ML, Izumi N, Huyen NN, Chow PK, Mohamed R, Chan SL, Tanwandee T, Lee TY, Hai TTN, Yang T, Lee WC, Chan HLY. Kim DY, et al. Among authors: chan hly, chan sl. Clin Mol Hepatol. 2023 Apr;29(2):277-292. doi: 10.3350/cmh.2022.0212. Epub 2023 Jan 30. Clin Mol Hepatol. 2023. PMID: 36710606 Free PMC article. Review.

2

Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers.

Wong VW, Chan SL, Mo F, Chan TC, Loong HH, Wong GL, Lui YY, Chan AT, Sung JJ, Yeo W, Chan HL, Mok TS. Wong VW, et al. Among authors: chan tc, chan hl, chan at, chan sl. J Clin Oncol. 2010 Apr 1;28(10):1660-5. doi: 10.1200/JCO.2009.26.2675. Epub 2010 Mar 1. J Clin Oncol. 2010. PMID: 20194845

3

Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis.

Liu K, Choi J, Le A, Yip TC, Wong VW, Chan SL, Chan HL, Nguyen MH, Lim YS, Wong GL. Liu K, et al. Among authors: chan hl, chan sl. Aliment Pharmacol Ther. 2019 Nov;50(9):1037-1048. doi: 10.1111/apt.15499. Epub 2019 Sep 16. Aliment Pharmacol Ther. 2019. PMID: 31524304

4

A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma.

Qin S, Chan SL, Sukeepaisarnjaroen W, Han G, Choo SP, Sriuranpong V, Pan H, Yau T, Guo Y, Chen M, Ren Z, Xu J, Yen CJ, Lin ZZ, Manenti L, Gu Y, Sun Y, Tiedt R, Hao L, Song W, Tanwandee T. Qin S, et al. Among authors: chan sl. Ther Adv Med Oncol. 2019 Dec 11;11:1758835919889001. doi: 10.1177/1758835919889001. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 31853265 Free PMC article.

5

Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.

Chan TT, Chan WK, Wong GL, Chan AW, Nik Mustapha NR, Chan SL, Chong CC, Mahadeva S, Shu SS, Lai PB, Chan HL, Wong VW. Chan TT, et al. Among authors: chan wk, chan hl, chan sl, chan aw. Am J Gastroenterol. 2020 Jun;115(6):867-875. doi: 10.14309/ajg.0000000000000588. Am J Gastroenterol. 2020. PMID: 32149781

6

Pattern and impact of hepatic adverse events encountered during immune checkpoint inhibitors - A territory-wide cohort study.

Chan SL, Yip TC, Wong VW, Tse YK, Yuen BW, Luk HW, Lui RN, Chan HL, Mok TS, Wong GL. Chan SL, et al. Among authors: chan hl. Cancer Med. 2020 Oct;9(19):7052-7061. doi: 10.1002/cam4.3378. Epub 2020 Aug 11. Cancer Med. 2020. PMID: 32780516 Free PMC article.

7

Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC.

Hui VW, Chan SL, Wong VW, Liang LY, Yip TC, Lai JC, Yuen BW, Luk HW, Tse YK, Lee HW, Chan HL, Wong GL. Hui VW, et al. Among authors: chan hl, chan sl. JHEP Rep. 2020 Jul 30;2(6):100152. doi: 10.1016/j.jhepr.2020.100152. eCollection 2020 Dec. JHEP Rep. 2020. PMID: 33024950 Free PMC article.

8

Hepatitis Flare During Immunotherapy in Patients With Current or Past Hepatitis B Virus Infection.

Wong GL, Wong VW, Hui VW, Yip TC, Tse YK, Liang LY, Lui RN, Mok TS, Chan HL, Chan SL. Wong GL, et al. Among authors: chan hl, chan sl. Am J Gastroenterol. 2021 Jun 1;116(6):1274-1283. doi: 10.14309/ajg.0000000000001142. Am J Gastroenterol. 2021. PMID: 33560651

9

Age and the relative importance of liver-related deaths in nonalcoholic fatty liver disease.

Lin H, Yip TC, Zhang X, Li G, Tse YK, Hui VW, Liang LY, Lai JC, Chan SL, Chan HL, Wong GL, Wong VW. Lin H, et al. Among authors: chan hl, chan sl. Hepatology. 2023 Feb 1;77(2):573-584. doi: 10.1002/hep.32633. Epub 2022 Jul 15. Hepatology. 2023. PMID: 35790018

10

Trends in risk factor control and treatment among patients with non-alcoholic fatty liver disease and type 2 diabetes between 2000 and 2020: A territory-wide study.

Zhang X, Yip TC, Tse YK, Hui VW, Li G, Lin H, Liang LY, Lai JC, Lai MS, Cheung JTK, Chan HL, Chan SL, Kong AP, Wong GL, Wong VW. Zhang X, et al. Among authors: chan hl, chan sl. Aliment Pharmacol Ther. 2023 May;57(10):1103-1116. doi: 10.1111/apt.17428. Epub 2023 Feb 23. Aliment Pharmacol Ther. 2023. PMID: 36815548

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

670 results

Search Page